Your browser doesn't support javascript.
loading
Palliative radiotherapy for locally advanced non-metastatic head and neck cancer: A systematic review.
Shahid Iqbal, Muhammad; Kelly, Charles; Kovarik, Josef; Goranov, Bojidar; Shaikh, Ghazia; Morgan, David; Dobrowsky, Werner; Paleri, Vinidh.
Afiliación
  • Shahid Iqbal M; Department of Clinical Oncology, Northern Centre for Cancer Care, The Newcastle upon Tyne Hospitals NHS Foundation Trust, United Kingdom. Electronic address: shahid.iqbal@nhs.net.
  • Kelly C; Department of Clinical Oncology, Northern Centre for Cancer Care, The Newcastle upon Tyne Hospitals NHS Foundation Trust, United Kingdom.
  • Kovarik J; Department of Clinical Oncology, Northern Centre for Cancer Care, The Newcastle upon Tyne Hospitals NHS Foundation Trust, United Kingdom.
  • Goranov B; Department of Clinical Oncology, Derriford Hospital, Plymouth, United Kingdom.
  • Shaikh G; Department of Clinical Oncology, Northern Centre for Cancer Care, The Newcastle upon Tyne Hospitals NHS Foundation Trust, United Kingdom.
  • Morgan D; Department of Physics, Northern Centre for Cancer Care, The Newcastle upon Tyne Hospitals NHS Foundation Trust, United Kingdom.
  • Dobrowsky W; Department of Clinical Oncology, Northern Centre for Cancer Care, The Newcastle upon Tyne Hospitals NHS Foundation Trust, United Kingdom.
  • Paleri V; The Royal Marsden NHS Foundation Trust, London, United Kingdom.
Radiother Oncol ; 126(3): 558-567, 2018 Mar.
Article en En | MEDLINE | ID: mdl-29370986
OBJECTIVES: The objective of this systematic review was to identify and appraise the existing evidence of role of palliative radiotherapy for locally advanced non-metastatic head and neck cancer. METHODS: A systematic search of the literature was conducted using Medline, Embase and Cochrane databases and relevant references were included. RESULTS: Literature search revealed a wide variation in dose fractionation regimens. Reported outcomes showed high efficacy and low rate of significant side effects, except in studies utilising higher doses of radiotherapy where higher grade toxicities were seen. Reported median overall survival was in the range of 3.3-17 months, but most studies reported median survival of around 6 months. CONCLUSIONS: The choice of palliative radiotherapy varies significantly. This is in contrast to regimens of curative radiotherapy for locally advanced head and neck cancer, which are well standardised. Given the reported relatively short overall survival of this patient group, an ideal treatment should be of the shortest possible duration whilst ensuring effective palliation and minimal side effects. Future well designed trials are needed to evaluate quality of life and duration of side effects in addition to survival and severity of toxicities in this group of patients.
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Cuidados Paliativos / Neoplasias de Cabeza y Cuello Tipo de estudio: Systematic_reviews Aspecto: Patient_preference Límite: Humans Idioma: En Revista: Radiother Oncol Año: 2018 Tipo del documento: Article Pais de publicación: Irlanda
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Cuidados Paliativos / Neoplasias de Cabeza y Cuello Tipo de estudio: Systematic_reviews Aspecto: Patient_preference Límite: Humans Idioma: En Revista: Radiother Oncol Año: 2018 Tipo del documento: Article Pais de publicación: Irlanda